Stocks / Concordia International Corp (NASDAQ: CXRX) / About cxrx Summary Profile Price History Financials Peer Comparison Share Info Performance Concordia International Corp (NASDAQ: CXRX) Latest News Investing No-Deal Brexit Will Have a Direct Impact on This Canadian Stock April 3, 2019 | Vishesh Raisinghani Advanz Pharma Corp's (TSX:ADVZ) sales are heavily exposed to Britain's economy. A messy Brexit could have a direct impact, according… Read more » Investing Legal Marijuana Could Be a Solution to the Opioid Epidemic! 1 Pharma Company That May Wish to Get Into the Weed Space July 3, 2018 | Joey Frenette Here's a company that may make a splash in the cannabis-based pharmaceuticals space, and it's not a producer like Canopy… Read more » Investing What Cannabis Stocks and Valeant Pharmaceuticals Intl Inc. (TSX:VRX) Have in Common June 17, 2018 | Chris MacDonald Here's what Canadian cannabis firms and Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) have in common. Hint: a lot. Read more » Investing A Complete Disaster: Inside Concordia International Corp.’s Worst Quarter Yet November 9, 2016 | Alexander John Tun Here's a postmortem look at Concordia International Corp.'s (TSX:CXR)(NASDAQ:CXRX) brutal third-quarter earnings release. Read more » Investing Concordia International Corp.: A Safe Buy? October 10, 2016 | Jacob Donnelly Concordia International Corp. (TSX:CXR)(NASDAQ:CXRX) is a risky, debt-ridden company that could grow quite handsomely if a series of steps are… Read more » Dividend Stocks How Will a Trump or Clinton Presidency Affect Your Portfolio? August 30, 2016 | Nelson Smith Do you own Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) or TransCanada Corporation (TSX:TRP)(NYSE:TRP) shares? Then pay attention to this election cycle. Read more » Investing Is Concordia International Corp. a Smart Buy at These Prices? August 26, 2016 | Jacob Donnelly Because of too much debt and a reduction in revenue, Concordia International Corp. (TSX:CXR)(NASDAQ:CXRX) is a risky investment. Read more » Dividend Stocks Concordia International Corp.’s Latest 50% Drop Is Attracting Some Institutional Investors August 17, 2016 | Scott Brandt Concordia International Corp. (TSX:CXR)(NASDAQ:CXRX) is caught in the wake of dismal earnings reports, negative sentiment about the pharmaceutical industry’s pricing… Read more » 1 2 3 ❯❯ ❯
Investing No-Deal Brexit Will Have a Direct Impact on This Canadian Stock April 3, 2019 | Vishesh Raisinghani Advanz Pharma Corp's (TSX:ADVZ) sales are heavily exposed to Britain's economy. A messy Brexit could have a direct impact, according… Read more »
Investing Legal Marijuana Could Be a Solution to the Opioid Epidemic! 1 Pharma Company That May Wish to Get Into the Weed Space July 3, 2018 | Joey Frenette Here's a company that may make a splash in the cannabis-based pharmaceuticals space, and it's not a producer like Canopy… Read more »
Investing What Cannabis Stocks and Valeant Pharmaceuticals Intl Inc. (TSX:VRX) Have in Common June 17, 2018 | Chris MacDonald Here's what Canadian cannabis firms and Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) have in common. Hint: a lot. Read more »
Investing A Complete Disaster: Inside Concordia International Corp.’s Worst Quarter Yet November 9, 2016 | Alexander John Tun Here's a postmortem look at Concordia International Corp.'s (TSX:CXR)(NASDAQ:CXRX) brutal third-quarter earnings release. Read more »
Investing Concordia International Corp.: A Safe Buy? October 10, 2016 | Jacob Donnelly Concordia International Corp. (TSX:CXR)(NASDAQ:CXRX) is a risky, debt-ridden company that could grow quite handsomely if a series of steps are… Read more »
Dividend Stocks How Will a Trump or Clinton Presidency Affect Your Portfolio? August 30, 2016 | Nelson Smith Do you own Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) or TransCanada Corporation (TSX:TRP)(NYSE:TRP) shares? Then pay attention to this election cycle. Read more »
Investing Is Concordia International Corp. a Smart Buy at These Prices? August 26, 2016 | Jacob Donnelly Because of too much debt and a reduction in revenue, Concordia International Corp. (TSX:CXR)(NASDAQ:CXRX) is a risky investment. Read more »
Dividend Stocks Concordia International Corp.’s Latest 50% Drop Is Attracting Some Institutional Investors August 17, 2016 | Scott Brandt Concordia International Corp. (TSX:CXR)(NASDAQ:CXRX) is caught in the wake of dismal earnings reports, negative sentiment about the pharmaceutical industry’s pricing… Read more »